Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
The Journal of General Virology|January 1, 1991
Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivityM Tisdale, T Schulze, B A Larder, et al.
Journal of Acquired Immune Deficiency Syndromes|November 1, 1993
Isolation and characterization of monoclonal antibodies raised against the reverse transcriptase of human immunodeficiency virus type 2 and cross-reactivity with that of type 1W Snowden, N Coughlan, M Tisdale, et al.
The Journal of Biological Chemistry|February 5, 1993
Enzymatic analysis of two HIV-1 reverse transcriptase mutants with mutations in carboxyl-terminal amino acid residues conserved among retroviral ribonucleases HS Volkmann, B M Wöhrl, M Tisdale, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1995
Inhibition of influenza virus transcription by 2'-deoxy-2'-fluoroguanosineM Tisdale, M Ellis, K Klumpp, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1994
Efficacy of 2'-deoxy-2'-fluororibosides against influenza A and B viruses in ferretsK J Jakeman, M Tisdale, S Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 15, 1993
Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3'-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptaseM Tisdale, S D Kemp, N R Parry, et al.
Nature|February 22, 1996
Characterization of a cancer cachectic factorP Todorov, P Cariuk, T McDevitt, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Efficacy of zanamivir against avian influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammalsI A Leneva, O Goloubeva, R J Fenton, et al.
AIDS Research and Human Retroviruses|March 1, 1991
Monoclonal antibodies define linear and conformational epitopes of HIV-1 pol gene productsR B Ferns, J C Partridge, M Tisdale, et al.
FEBS Letters|June 3, 1991
Rapid purification and characterisation of HIV-1 reverse transcriptase and RNaseH engineered to incorporate a C-terminal tripeptide alpha-tubulin epitopeD K Stammers, M Tisdale, S Court, et al.
Pageof 5